UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 6
June-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2206783


Registration ID:
404867

Page Number

h735-h762

Share This Article


Jetir RMS

Title

Effects of Low-Dose acetylsalicylic acid (Aspirin) + Fish Oil in Patients with Diabetes Mellitus

Abstract

Aspirin, also known as acetylsalicylic acid (ASA), is a medication used to reduce pain, fever or inflammation. Many diabetics are insensitive to aspirin’s platelet anti-aggregation effects. The possible modulating effects of coadministration of aspirin and fish oil in subjects with diabetes are poorly characterized. Aspirin alone and in combination with fish oil reduced platelet aggregation in most participants. Five of 7 participants classified as aspirin insensitive 1 week after daily aspirin ingestion were sensitive after the combination. Although some platelet aggregation measures correlated positively after aspirin and fish oil ingestion alone and (in combination) in all individuals, correlation was only observed in those who were aspirin insensitive after ingestion of the combination. However, the benefits of combining EPA (eicosapentaenoic acid) + DHA (docosahexaenoic acid) with aspirin on platelet function or other inflammatory parameters have not received much attention. We hypothesized that the combination of low-dose aspirin and ω3 fatty acids of fish oil would be more effective than aspirin alone in reducing platelet aggregation and related mechanisms that potentiate the atherosclerotic process in subjects with type II diabetes.

Key Words

Aspirin, also known as acetylsalicylic acid (ASA), is a medication used to reduce pain, fever or inflammation. Many diabetics are insensitive to aspirin’s platelet anti-aggregation effects. The possible modulating effects of coadministration of aspirin and fish oil in subjects with diabetes are poorly characterized. Aspirin alone and in combination with fish oil reduced platelet aggregation in most participants. Five of 7 participants classified as aspirin insensitive 1 week after daily aspirin ingestion were sensitive after the combination. Although some platelet aggregation measures correlated positively after aspirin and fish oil ingestion alone and (in combination) in all individuals, correlation was only observed in those who were aspirin insensitive after ingestion of the combination. However, the benefits of combining EPA (eicosapentaenoic acid) + DHA (docosahexaenoic acid) with aspirin on platelet function or other inflammatory parameters have not received much attention. We hypothesized that the combination of low-dose aspirin and ω3 fatty acids of fish oil would be more effective than aspirin alone in reducing platelet aggregation and related mechanisms that potentiate the atherosclerotic process in subjects with type II diabetes.

Cite This Article

"Effects of Low-Dose acetylsalicylic acid (Aspirin) + Fish Oil in Patients with Diabetes Mellitus", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.h735-h762, June-2022, Available :http://www.jetir.org/papers/JETIR2206783.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Effects of Low-Dose acetylsalicylic acid (Aspirin) + Fish Oil in Patients with Diabetes Mellitus", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. pph735-h762, June-2022, Available at : http://www.jetir.org/papers/JETIR2206783.pdf

Publication Details

Published Paper ID: JETIR2206783
Registration ID: 404867
Published In: Volume 9 | Issue 6 | Year June-2022
DOI (Digital Object Identifier):
Page No: h735-h762
Country: MUMBAI, Maharashtra, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000298

Print This Page

Current Call For Paper

Jetir RMS